share_log

Halozyme Therapeutics | 8-K: HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS

SEC ·  Nov 1 04:12
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more